Cinacalcet exhibits rapid bactericidal and efficient anti-biofilm activities against multidrug-resistant Gram-positive pathogens
- iScience. 2023 Mar 11;26(4):106378. doi: 10.1016/j.isci.2023.106378.
- 1. Department of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Shenzhen Nanshan People's Hospital and the 6th Affiliated Hospital of Shenzhen University Medical School, Shenzhen 518052, China.
- 2. College of Biotechnology and Pharmaceutical Engineering, Nanjing University of Technology, Nanjing 211816, China.
- 3. Department of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Affiliated Shenzhen Sixth Hospital of Guangdong Medical University, Shenzhen, China.
Infections caused by Gram-positive bacteria pose a serious threat to global public health. Drug resistance, dormant persister cells, and biofilm formation are the key challenges affecting the efficacy of Antibiotics against Gram-positive Bacterial infections. In this study, cinacalcet exhibited good inhibitory activity against multidrug-resistant Gram-positive bacteria, with minimum inhibitory concentrations (MICs) ranging from 3.13 μg/mL to 25 μg/mL. Cinacalcet displayed more rapid and stronger bactericidal activity against planktonic and persister cells of Staphylococcus aureus and Enterococcus faecalis compared with the Antibiotics vancomycin or ampicillin, as well as potent inhibition and eradication of mature biofilms of methicillin-resistant S. aureus (MRSA) and linezolid-resistant E. faecalis (LRE). In addition, the robust Antibacterial activity was demonstrated in vivo by a pneumonia Infection model and a biofilm formation and deep-seated Infection model. Collectively, these findings indicate that cinacalcet may be a promising new candidate Antibiotic to combat infections caused by multidrug-resistant Gram-positive pathogens.